Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLS.L Regulatory News (SLS)

  • There is currently no data for SLS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison issues review on Standard Life UK Small.Co'

11 Dec 2018 15:40

RNS Number : 1540K
Standard Life UK Small.Co's Tst PLC
11 December 2018
 

 

London, UK, 11 December 2018

Edison issues review on Standard Life UK Smaller Companies (SLS)

Standard Life UK Smaller Companies (SLS) is managed by Harry Nimmo at Aberdeen Standard Investments. He has followed the same investment process since he took over management of the trust in 2003, through a number of economic cycles, and considers it to be stable, predictable and well defined, while providing an element of resilience during periods of stock market weakness. He also believes that the investment process is optimal for running large amounts of UK small-cap money. Nimmo has a long-term record of outperformance - SLS's NAV total return is ahead of its blended benchmark over the last one, three, five and 10 years, and above the averages of its larger peers in the AIC UK Smaller Companies sector over one and five years, and broadly in line over three years.

 

SLS's current 8.4% share price discount to cum-income NAV is wider than the 4.8% to 5.4% range of average discounts over the last one, three, five and 10 years. The board actively manages the discount, aiming to keep it below 8% (in normal market conditions - see page 7). This is achieved primarily via share repurchases. While the trust's objective is to generate long-term growth rather than income, SLS also offers a dividend yield of 1.7%.

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisoninvestmentresearch.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Mel Jenner, +44 (0)20 3077 5720

Gavin Wood, +44 (0)20 3681 2503

investmenttrusts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-investment-research 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRATBBATMBJBBMP
Date   Source Headline
3rd Jun 20215:07 pmRNSTransaction in Own Shares
3rd Jun 202111:34 amRNSNet Asset Value(s)
2nd Jun 202112:01 pmRNSNet Asset Value(s)
1st Jun 20214:59 pmRNSTransaction in Own Shares
1st Jun 20213:07 pmRNSGearing disclosure
1st Jun 202110:14 amRNSTotal Voting Rights
28th May 20214:56 pmRNSTransaction in Own Shares
28th May 202112:33 pmRNSNet Asset Value(s)
27th May 20215:05 pmRNSTransaction in Own Shares
27th May 202111:35 amRNSNet Asset Value(s)
26th May 20215:10 pmRNSTransaction in Own Shares
26th May 202112:19 pmRNSNet Asset Value(s)
25th May 20215:04 pmRNSTransaction in Own Shares
25th May 202111:46 amRNSNet Asset Value(s)
24th May 20212:45 pmRNSGearing Disclosure
24th May 202112:15 pmRNSNet Asset Value(s)
21st May 202112:06 pmRNSNet Asset Value(s)
20th May 202111:16 amRNSNet Asset Value(s)
19th May 202112:38 pmRNSNet Asset Value(s)
18th May 202111:18 amRNSNet Asset Value(s)
17th May 20213:25 pmRNSPortfolio disclosure
17th May 20212:44 pmRNSGearing disclosure
17th May 202112:06 pmRNSNet Asset Value(s)
14th May 202112:36 pmRNSNet Asset Value(s)
13th May 202112:31 pmRNSNet Asset Value(s)
12th May 202112:33 pmRNSNet Asset Value(s)
11th May 202112:30 pmRNSNet Asset Value(s)
11th May 20219:09 amRNSIncreased Loan Facility
10th May 202112:48 pmRNSGearing disclosure
10th May 202111:35 amRNSNet Asset Value(s)
7th May 20213:04 pmRNSMonth End Net Asset Value(s)
7th May 202111:03 amRNSNet Asset Value(s)
6th May 202111:17 amRNSNet Asset Value(s)
5th May 202111:22 amRNSNet Asset Value(s)
4th May 20211:07 pmRNSGearing disclosure
4th May 20217:00 amRNSBlock listing Interim Review
30th Apr 202112:31 pmRNSNet Asset Value(s)
29th Apr 202111:20 amRNSNet Asset Value(s)
28th Apr 202112:18 pmRNSNet Asset Value(s)
27th Apr 202111:55 amRNSNet Asset Value(s)
27th Apr 20217:00 amRNSEdison review on Standard Life UK Smaller Co's
26th Apr 202111:33 amRNSGearing disclosure
26th Apr 202110:59 amRNSNet Asset Value(s)
23rd Apr 202111:24 amRNSNet Asset Value(s)
22nd Apr 202110:50 amRNSNet Asset Value(s)
21st Apr 202111:10 amRNSNet Asset Value(s)
20th Apr 202111:38 amRNSNet Asset Value(s)
19th Apr 20212:37 pmRNSGearing Disclosures
19th Apr 202112:03 pmRNSNet Asset Value(s)
16th Apr 202111:10 amRNSPortfolio disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.